Amgen

Amgen Inc. is one of the world’s leading biotechnology companies and is widely recognized as a pioneer in the development of innovative biologic medicines. Founded in 1980 and headquartered in Thousand Oaks, California, USA, the company combines advanced biology with cutting-edge technology to develop therapies for serious diseases including cancer, cardiovascular disorders, inflammation, osteoporosis, rare diseases, and nephrology. Amgen has built a strong reputation for translating scientific discoveries into life-changing medicines through extensive research, genetic analysis, and biotechnology innovation.

The company invests billions of dollars annually in research and development, operating research centers and manufacturing facilities across North America, Europe, Asia-Pacific, and Latin America. Its product portfolio includes numerous blockbuster biologic medicines that serve millions of patients worldwide. In addition to internal innovation, Amgen continues to expand through strategic acquisitions and collaborations that strengthen its pipeline in oncology, immunology, and precision medicine.

Amgen is committed to sustainable manufacturing, ethical business practices, and improving global access to healthcare. Its manufacturing network follows stringent international quality standards while supporting reliable supply chains for healthcare providers worldwide. The company also actively supports scientific education, community initiatives, and environmental sustainability through the Amgen Foundation and various corporate responsibility programs. Today, Amgen remains one of the largest and most influential biotechnology companies, driving innovation that continues to shape the future of modern medicine.